NCT01307592 2014-01-10Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown70 enrolled